Gilead issues RFP to evaluate patient-reported outcomes associated with treatment of the hepatitis B virus

Last update: Apr 25, 2025 Last update: Apr 25, 2025

Details

Location:

USA

Funding agency:

Other

Contracting authority: Gilead Sciences, Inc.

Contracting authority type:Supplier / manufacturer

Status:Closed

Budget:N/A

Award ceiling: USD 200,000

Award floor:N/A

Sector:Health, Research & Innovation

Languages:English

Eligible applicants:Individuals

Eligible citizenships:

USA

Date posted: Apr 25, 2025

Attachments • 1

Associated Awards

Description

Gilead issues RFP to evaluate patient-reported outcomes associated with treatment of the hepatitis B virus Deadline: May 19, 2025 Working to advance the care of patients suffering from life-threatening diseases worldwide, Gilead Sciences is a biopharmaceu

Want to unlock full information?

Member-only information. Become a member to access this information. Procurement notices from over 850+ sources of tenders and grants published by donors, development banks, foundations, and international financial institutions (IFIs) are available here.

Learn more about our membership benefits